Clinical Trial Update: Efficacy and Tolerability of Low-Dose Enzalutamide in Prostate Cancer

View source ↗

Summary

This document reports a clinical trial evaluating low-dose enzalutamide for metastatic prostate cancer; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)

Snippet

Sponsor: Monica Boitano | Conditions: Prostate Cancer Metastatic Disease | Status: NOT_YET_RECRUITING